The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Ian S Hagemann,Wei Deng,Richard J Zaino,Matthew A Powell,Camille Gunderson,Casey Cosgrove,Cara Mathews,Michael L Pearl,Steven Waggoner,Rahel Ghebre,Shashikant Lele,Saketh Guntupalli,Angeles Alvarez Secord,Olga Ioffe,Kay Park,Golnar Rasty,Meenakshi Singh,Robert Soslow,William Creasman, David G Mutch

Gynecologic Oncology（2021）

引用 8|浏览90

暂无评分

摘要

•663 pure uterine serous cancers were compared with 138 mixed serous-endometrioid and 133 indeterminate cases.•Pure, mixed and indeterminate serous carcinomas had similar clinicopathologic characteristics.•On multiple regression, the presence of an endometrioid component did not independently predict survival.

查看译文

关键词

Endometrial carcinoma,Endometrioid carcinoma,Serous carcinoma,Malignant mixed tumors,Pathology,Survival analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要